Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ringer's Lactate Temperature Effects on Circulation
NCT05610254Phase 4Completed
- Sponsor
- Esbjerg Hospital - University Hospital of Southern Denmark
- Start
- Oct 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lactated ringer's solution in hemodynamic instability, sponsored by Esbjerg Hospital - University Hospital of Southern Denmark. Primary endpoint: Mean Arterial Pressure Increase at 15 minutes. Started Oct 2022; status: completed.
02
Drugs
lactated ringer's solution
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT05610254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05610254.